The German supplier of human dura mater blamed for a number of cases of the fatal Creutzfeldt-Jakob disease in Japan plans to reach a negotiated settlement on suits filed by patients and victims' families, the company said in a statement Wednesday.
B. Braun Melsungen AG said in the statement, "For an early resolution, we will present a settlement proposal tomorrow to the Tokyo and Otsu district courts that will include specific figures and conditions," although it does not agree to several key disputed points in the suits.
The company declined to disclose details of its proposal now as it would affect many delicate issues, but it is ready to disclose them at a later date as it deems fit, according to the statement.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.